For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab74062? Please let us know so that we can cite the reference in this datasheet.
ab74062 has been referenced in 3 publications.
- Rao SS et al. Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer. Oncotarget 8:83925-83939 (2017).
- Jeon WK et al. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-ß1-induced growth inhibition by targeting Smad3 linker region. Oncotarget 6:41650-66 (2015).
- Browne JA et al. Serine-204 in the linker region of Smad3 mediates the collagen-I response to TGF-ß in a cell phenotype-specific manner. Exp Cell Res 319:2928-37 (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"